Sildenafil citrate and uteroplacental perfusion in fetal growth restriction

Background: To determine whether the phosphodiesterase type 5 inhibitor, Sildenafil citrate, affects uteroplacental perfusion. Materials and Methods: Based on a randomized double-blinded and placebo-controlled trial, forty one pregnant women with documented intrauterine growth retardation at 24-37 w...

Full description

Bibliographic Details
Main Authors: Marzieh Vahid Dastjerdi, Sayedehafagh Hosseini, Leila Bayani
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2012-01-01
Series:Journal of Research in Medical Sciences
Subjects:
Online Access:http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2012;volume=17;issue=7;spage=632;epage=636;aulast=Dastjerdi